Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Daily Market Download

Amgen Inc. Quarterly Report: June 30, 2025

06 Aug 2025

Description

This document is a Quarterly Report (Form 10-Q) filed by Amgen Inc. with the U.S. Securities and Exchange Commission, providing a comprehensive overview of the company's financial performance for the three and six months ended June 30, 2025. It includes condensed consolidated financial statements (income, comprehensive income, balance sheets, cash flows), notes to those statements, and management's discussion and analysis of the company's financial condition and results of operations. The report details product sales, operating expenses, tax matters, investment portfolio information, and outlines legal proceedings, contingencies, and risks such as those related to government pricing policies and global economic conditions, fulfilling regulatory disclosure requirements.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.